Clinical trial NCT02367222 - References

Multiple Sclerosis — A Database Study to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada

Citation(s)

•   Ascherio A, Munger KL, Lünemann JD
  The initiation and prevention of multiple sclerosis. Nat Rev Neurol. 2012 Nov 5;8(11):602-12. doi: 10.1038/nrneurol.2012.198. Epub 2012 Oct 9. Review.
•   Ascherio A, Zhang SM, Hernán MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM
  Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med. 2001 Feb 1;344(5):327-32.
•   Bansil S, Troiano R, Dowling PC, Cook SD
  Measles vaccination does not prevent multiple sclerosis. Neuroepidemiology. 1990;9(5):248-54.
•   Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F
  Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BM
•   Beck CA, Metz LM, Svenson LW, Patten SB
  Regional variation of multiple sclerosis prevalence in Canada. Mult Scler. 2005 Oct;11(5):516-9.
•   Canadian Institute for Health Information (2006)
  Canadian Classification of Health Interventions (Ottawa, Ontario, Canada).
•   Casetta I, Granieri E, Malagù S, Tola MR, Paolino E, Caniatti LM, Govoni V, Monetti VC, Fainardi E
  Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy. Neuroepidemiology. 1994;13(3):1
•   Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S; Vaccines in Multiple Sclerosis Study Group
  Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med. 2001 Feb 1;344(5):319-26.
•   Cosby SL, McQuaid S, Taylor MJ, Bailey M, Rima BK, Martin SJ, Allen IV
  Examination of eight cases of multiple sclerosis and 56 neurological and non-neurological controls for genomic sequences of measles virus, canine distemper virus, simian virus 5 and r
•   Cummings P, McKnight B, Greenland S
  Matched cohort methods for injury research. Epidemiol Rev. 2003;25:43-50. Review. Erratum in: Epidemiol Rev. 2004 Aug 1;160(3):300.
•   Currier RD, Meydrech EF, Currier MM
  Measles vaccination has had no effect on the occurrence of multiple sclerosis. Arch Neurol. 1996 Dec;53(12):1216.
•   Dean G
  How many people in the world have multiple sclerosis? Neuroepidemiology. 1994;13(1-2):1-7.
•   DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, Shinefield HR, Mullooly JP, Likosky W, Chen RT; Vaccine Safety Datalink Research Group, National Immunization Program, Centers for Disease Control and Prevention
  Vaccinations and risk
•   Dublin S, Jackson ML, Nelson JC, Weiss NS, Larson EB, Jackson LA
  Statin use and risk of community acquired pneumonia in older people: population based case-control study. BMJ. 2009 Jun 16;338:b2137. doi: 10.1136/bmj.b2137.
•   Elixhauser A, Steiner C, Harris DR, Coffey RM
  Comorbidity measures for use with administrative data. Med Care. 1998 Jan;36(1):8-27.
•   Farez MF, Ysrraelit MC, Fiol M, Correale J
  H1N1 vaccination does not increase risk of relapse in multiple sclerosis: a self-controlled case-series study. Mult Scler. 2012 Feb;18(2):254-6. doi: 10.1177/1352458511417253. Epub 2011 Aug 9.
•   Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL
  Clinical effectiveness of influenza vaccination in Manitoba. JAMA. 1993 Oct 27;270(16):1956-61. Erratum in: JAMA 1994 May 25;271(20):1578.
•   Fleiss J L Levin B, Paik M C
  (2003). Statistical Methods for Rates and Proportions (3rd ed.) (Formulas 3.18 &3.19). New York: John Wiley & Sons.
•   Haase AT, Ventura P, Gibbs CJ Jr, Tourtellotte WW
  Measles virus nucleotide sequences: detection by hybridization in situ. Science. 1981 May 8;212(4495):672-5.
•   Hammerschlag MR, Ke Z, Lu F, Roblin P, Boman J, Kalman B
  Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis? J Clin Microbiol. 2000 Nov;38(11):4274-6.
•   Hardy JR, Holford TR, Hall GC, Bracken MB
  Strategies for identifying pregnancies in the automated medical records of the General Practice Research Database. Pharmacoepidemiol Drug Saf. 2004 Nov;13(11):749-59.
•   Humphries KH, Rankin JM, Carere RG, Buller CE, Kiely FM, Spinelli JJ
  Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review? J Clin Epidemiol. 2000 Apr;53(4):343-9.
•   Kakalacheva K, Lünemann JD
  Environmental triggers of multiple sclerosis. FEBS Lett. 2011 Dec 1;585(23):3724-9. doi: 10.1016/j.febslet.2011.04.006. Epub 2011 Apr 7. Review.
•   Kelsey JL, Whittemore AS, Evans AS, Thompson WD (1996)
  Methods in Observational Epidemiology (2nd Edition) (Table 12-15) Oxford University Press.
•   Kozyrskyj AL, Mustard CA
  Validation of an electronic, population-based prescription database. Ann Pharmacother. 1998 Nov;32(11):1152-7.
•   Lix L, Yogendran M, Burchill C, et al
  , (2006). Defining and Validating Chronic Diseases: An Administrative Data Approach (Winnipeg, Manitoba Centre for Health Policy).
•   Mahmud S, Hammond G, Elliott L, Hilderman T, Kurbis C, Caetano P, Van Caeseele P, Kettner J, Dawood M
  Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study. Vaccine. 2011 O
•   Mahmud SM, Van Caeseele P, Hammond G, Kurbis C, Hilderman T, Elliott L
  No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009. Emerg Infect Dis. 2012 May;18(5):801-10. doi: 10.3201/eid1805.1115
•   Marrie RA, Yu N, Blanchard J, Leung S, Elliott L
  The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology. 2010 Feb 9;74(6):465-71. doi: 10.1212/WNL.0b013e3181cf6ec0. Epub 2010 Jan 13. Erratum in: Neurology. 2011 S
•   Marrie RA
  Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004 Dec;3(12):709-18. Review.
•   MCHP Guidelines for Public and Private Sponsorship of Research Projects Accessing the Population Health Data Repository (2011); http://umanitoba
  ca/faculties/medicine/units/community_health_sciences/departmental_units/mchp/protocol/media/Private_Sector_Sp
•   McNicholas N, Chataway J
  Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination. J Neurol. 2011 Aug;258(8):1545-7. doi: 10.1007/s00415-011-5944-x. Epub 2011 Feb 19.
•   Nortvedt MW, Riise T, Myhr KM, Nyland HI
  Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology. 1999 Sep 22;53(5):1098-103.
•   OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 3
  01, Released April 4 and revised April 6, 2013, http://www.openepi.com/v37/SampleSize/SSPropor.htm.
•   Parsons L S (2001)
  Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Paper presented at: Proceedings of the Twenty-sixth Annual SAS Users group international conference (SAS Institute, Inc.); pp. 214-26.
•   Persson I, Granath F, Askling J, Ludvigsson JF, Olsson T, Feltelius N
  Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up.
•   Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F
  Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology. 1991 May;41(5):692-6.
•   Roberts JD, Poffenroth LA, Roos LL, Bebchuk JD, Carter AO
  Monitoring childhood immunizations: a Canadian approach. Am J Public Health. 1994 Oct;84(10):1666-8.
•   Roberts JD, Roos LL, Poffenroth LA, Hassard TH, Bebchuk JD, Carter AO, Law B
  Surveillance of vaccine-related adverse events in the first year of life: a Manitoba cohort study. J Clin Epidemiol. 1996 Jan;49(1):51-8.
•   Robinson JR, Young TK, Roos LL, Gelskey DE
  Estimating the burden of disease. Comparing administrative data and self-reports. Med Care. 1997 Sep;35(9):932-47.
•   Roos LL, Mustard CA, Nicol JP, McLerran DF, Malenka DJ, Young TK, Cohen MM
  Registries and administrative data: organization and accuracy. Med Care. 1993 Mar;31(3):201-12.
•   Rubin DB
  Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997 Oct 15;127(8 Pt 2):757-63. Review.
•   Singh H, Demers AA, Nugent Z, Mahmud SM, Kliewer EV, Bernstein CN
  Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. Gastroenterology. 2009 Feb;136(2):451-8. doi: 10.1053/j.gastro.2008.1
•   Singh H, Mahmud SM, Turner D, Xue L, Demers AA, Bernstein CN
  Long-term use of statins and risk of colorectal cancer: a population-based study. Am J Gastroenterol. 2009 Dec;104(12):3015-23. doi: 10.1038/ajg.2009.574. Epub 2009 Oct 6.
•   Skarsgard D, Tonita J
  Prostate cancer in Saskatchewan Canada, before and during the PSA era. Cancer Causes Control. 2000 Jan;11(1):79-88.
•   Therneau T M, Grambsch P M (2000)
  Modeling Survival Data: Extending the Cox Model (New York, Springer).
•   Thompson LH, Mahmud SM, Keynan Y, Blanchard JF, Slater J, Dawood M, Fowke K, Van Caeseele P, Becker M
  Serological survey of the novel influenza A H1N1 in inner city Winnipeg, Manitoba, 2009. Can J Infect Dis Med Microbiol. 2012 Summer;23(2):65-70.
•   Vrethem M, Malmgren K, Lindh J
  A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination. J Neurol Sci. 2012 Oct 15;321(1-2):89-91. doi: 10.1016/j.jns.2012.07.025. Epub 2012 Jul 28.
•   WHO Collaborating Centre for Drug Statistics Methodology (2002)
  ATC Index With DDDs (WHO, Oslo, Norway,).
•   WHO
  International statistical classification of diseases and related health problems, Tenth Revision (1993) (WHO, Geneva, Switzerland).
•   Zarychanski R, Stuart TL, Kumar A, Doucette S, Elliott L, Kettner J, Plummer F
  Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ. 2010 Feb 23;182(3):257-64. doi: 10.1503/cmaj.091884. Epub 2010 Jan 21.
•   Zorzon M, Zivadinov R, Nasuelli D, Dolfini P, Bosco A, Bratina A, Tommasi MA, Locatelli L, Cazzato G
  Risk factors of multiple sclerosis: a case-control study. Neurol Sci. 2003 Nov;24(4):242-7.

An Observational Retrospective Database Analysis to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada

Details for clinical trial NCT02367222